Breast Cancer

HER 2 Negative Breast Cancer

Female, 45 years

Patient Internal ID: 495720

ICD-10 code

C50.5 Malignant Neoplasm of Lower Outer Quadrant of Breast

Diagnosis (Incl. Metastases/Stage) and Year

June 2022
Invasive Poorly Differentiated Ductal Carcinoma of the Right Breast G3 pT2pN0(sn)M0 Stage II A, LVI-0, ER (+), PR (-), HER2(1+), Ki67 – 3% (up to 10% in Hot Spots).

Previous Treatment

Surgery, Hormone Therapy (Tamoxifen), Radiation Therapy.

Prognosis and Survival Expectation

Estrogen-Receptor Positive Breast Cancer has a median overall survival (OS) of 37 months. The overall survival rate of Breast Cancer patients on Estrogen Positive  Receptors was 41.51%.

Treatment Provided

Autologous DCV (5 doses) and CIK (4 doses) over a period of 4 months.

Patient Survival/Condition and Year
Date of Review: 30/12/2023

The patient has survived for 18 months since the diagnosis so far. No signs of disease progression.
The patient continues treatment with Tamoxifen and has regular follow-up visits.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok